Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study to Assess Aesthetic Improvement and Onset of QM1114-DP Treatment Effect in Subjects With Moderate to Severe Glabellar Lines

The objective of this study is to evaluate the aesthetic improvement and onset of QM1114-DP treatment for subjects with moderate to severe glabellar lines

Inclusion Criteria:

• Male or Female 18 years or older
• Moderate to severe GL at maximum frown as assessed by the Investigator
• Moderate to severe GL at maximum frown as assessed by the subject

Exclusion Criteria:

• Previous use of any botulinum toxin in facial areas within 9 months prior to study treatment
• Female who is pregnant, breast feeding or intends to conceive a child during the study.